Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors

Brain Research

Volumn 1178, Issue 1, 2007, Pages 44-51

  Ohno, Yukihiro ^a,c   Hibino, Hiroshi ^a   Lossin, Christoph ^a   Inanobe, Atsushi ^a   Kurachi, Yoshihisa ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antidepressant; Astrocyte; Inwardly rectifying potassium channel; Selective serotonin reuptake inhibitor; Spatial potassium buffering

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; FLUOXETINE; FLUVOXAMINE MALEATE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR4.1; MIANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN FUNCTION; BRAIN REGION; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; IC 50; MACROGLIA; PATCH CLAMP; PRIORITY JOURNAL; WHOLE CELL;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ASTROCYTES; CELLS, CULTURED; DATA INTERPRETATION, STATISTICAL; ELECTROPHYSIOLOGY; FLUOXETINE; HUMANS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEROTONIN UPTAKE INHIBITORS; TRANSFECTION;

EID: 35448954314     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.018     Document Type: Article

References (41)

1. Barbey J.T., and Roose S.P. SSRI safety in overdose. J. Clin. Psychiatry 59 Suppl. 15 (1998) 42-48
2. Briner K., and Dodel R.C. New approaches to rapid onset antidepressants. Curr. Pharm. Des. 4 (1998) 291-302
3. Choi J.-S., Hahn S.J., Rhie D.-J., Yoon S.-H., Jo Y.-H., and Kim M.-S. Mechanism of fluoxetine block of cloned voltage-activated potassium channels Kv1.3. J. Pharmacol. Exp. Ther. 291 (1999) 11-16
4. Czeh B., Simon M., Schmelting B., Hiemks C., and Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31 (2006) 1616-1626
5. Frazer A. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. J. Clin. Psychiatry 62 (2001) 16-23
6. Fuchs E., Czeh B., Kole M.H.P., Michaelis T., and Lucassenm P.J. Alterations of neuroplasiticity in depression: the hippocampus and beyond. Eur. Neuropsychopharmacol. 14 (2004) S481-S490
7. Glotzbach R.K., and Preskorn S.H. Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology (Berl.) 78 (1982) 25-27
8. Guo W.Y., Todd K.G., Bourin M., and Hascoet M. The additive effects of quinine on antidepressant drugs in the forced swimming test in mice. Psychopharmacology (Berl.) 121 (1995) 173-179
9. Guo W.Y., Todd K.G., Bourin M., Hascoet M., and Kouadio F. Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol. Biochem. Behav. 54 (1996) 725-730
10. Henry M.E., Schmidt M.E., Hennen J., Villafuerte R.A., Butman M.L., Tran P., Kerner L.T., Cohen B., and Renshaw P. A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 30 (2005) 1576-1583
11. + channels subunits, Kir4.1 and Kir5.1, in brain astrocytes. J. Biol. Chem. 279 (2004) 44065-44073
12. Higashi K., Fujita A., Inanobe A., Tanemoto M., Dioi K., Kubo T., and Kurachi Y. An inwardly rectifying K(+) channel Kir4.1 expressed in astrocytes surrounds synapses and blood vessels in brain. Am. J. Physiol., Cell Physiol. 281 (2001) C922-C931
13. Horio Y., Morishige K., Takahashi N., and Kurachi Y. Differential distribution of classical inwardly rectifying potassium channel mRNAs in the brain; comparison of IRK2 with IRK1 and IRK3. FEBS Lett. 379 (1996) 239-243
14. + channels in retina. Am. J. Physiol., Cell Physiol. 285 (2003) C260-C267
15. Isomoto S., Kondo C., and Kurachi Y. Inwardly rectifying potassium channels: their molecular heterogeneity and function. Jpn. J. Physiol. 47 (1997) 11-39
16. Karson C.N., Newton J.E.O., Livingston R., Jolly J.B., Cooper T.B., Sprigg J., and Komoroski R.A. Human brain fluoxetine concentrations. J. Neuropsychiat. Clin. Neurosci. 5 (1993) 322-329
17. Kaster M.P., Ferreira P.K., Santos A.R., and Rodrigues A.L. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res. 165 (2005) 204-209
18. Kenna S., Ropert S., Ashcroft S.J.H., and Ashcroft F.M. Differential expression of the inwardly-rectifying K-channel ROMK1 in rat brain. Mol. Brain Res. 24 (1994) 353-356
19. + channels by fluoxetine (Prozac). Br. J. Pharmacol. 138 (2003) 1119-1128
20. + channels by various antidepressant drugs. Neuropsychopharmacology 29 (2004) 1841-1851
21. Kofuji P., and Newman E.A. Potassium buffering in the central nervous system. Neuroscience 129 (2004) 1045-1056
22. + channel, ROMK6 (Kir1.1f). FEBS Lett. 399 (1996) 122-126
23. Kubo Y., Adelman J.P., Clapham D.E., Jan L.Y., Karschin A., Kurachi Y., Lazdunski M., Nichols C.G., Seino S., and Vandenberg C.A. International Union of Pharmacology: LIV. Nomenclature and molecular relationship of inwardly rectifying potassium channels. Pharmacol. Res. 57 (2005) 509-526
24. Kucheryavykh Y.V., Kucheryavykh L.Y., Nichols C.G., Maldonado H.M., Baksi K., Reichenbach A., Skatchkov S.N., and Eaton M.J. Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes. Glia 55 (2007) 274-281
25. Mercier G., Lennon A.M., Renouf B., Dessouroux A., Ramauge M., Courtin F., and Pierre M. MAP kinase activation by fluoxetine and its relationship to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 24 (2004) 207-216
26. Malberg J.E., and Blendy J.A. Antidepressant action: to the nucleus and beyond. Trends Pharmacol. Sci. 26 (2005) 631-638
27. Morishige K.-I., Takahashi N., Findlay I., Koyama H., Zanelli J.S., Peterson C., Jenkins N.A., Copeland N.G., Mori N., and Kurachi Y. Molecular cloning, functional expression and localization of an inward rectifier potassium channel in the mouse brain. FEBS Lett. 336 (1993) 375-380
28. Ninan P.T. Obsessive-compulsive disorder: implication of the efficacy of an SSRI, paroxetine. Psychopharmacol. Bull. 37 Suppl 1 (2003) 89-96
29. Ohno-Shosaku T., and Yamamoto C. Identification of an ATP-sensitive K channel in rat cultured cortical neurons. Pflügers Arch. 422 (1992) 260-266
30. Pisani F., Spina E., and Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40 Suppl. 10 (1999) S48-S56
31. Pollack M.H., and Marzol P.C. Panic: course, complications and treatment of panic disorder. J. Psychopharmacol. 14 2 Suppl 2 (2000) S25-S30
32. Poopalasundaram S., Knott C., Shamotienko O.G., Foran P.G., Dolly J.O., Ghiani C.A., Gallo V., and Wilkin G.P. Glial heterogeneity in expression of the inwardly rectifying K(+) channel Kir4.1. in adult rat CNS. Glia 30 (2000) 362-372
33. Rani P.U., Naidu M.U.R., Prasad V.B.N., Rao T.R.K., and Shobha J.C. An evaluation of antidepressants in rheumatic pain conditions. Anesth. Analg. 83 (1996) 371-375
34. Sanchez C., and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19 (1999) 467-489
35. Simard M., and Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129 (2004) 877-896
36. Su S., Ohno Y., Lossin C., Hibino H., Inanobe A., and Kurachi Y. Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline. J. Pharmacol. Exp. Ther. 320 (2007) 573-580
37. Takumi T., Ishii T., Hirio Y., Morishige K., Takahashi N., Yamada M., Yamashita T., Kiyama H., Sohmiya K., Nakanishi S., and Kurachi Y. A novel ATP-dependent inward rectifier potassium channel expressed predominantly in glial cells. J. Biol. Chem. 270 (1995) 16339-16346
38. + channel by heteromeric subunit assembly of Kir5.1 with Kir4.1. J. Physiol. 525 (2000) 587-592
39. Thomas D., Gut B., Wendt-Nordahl G., and Kiehn J. The antidepressant drug is an inhibitor of human either-a-go-go-related gene (HERG) potassium channels. J. Pharmacol. Exp. Ther. 300 (2002) 543-548
40. Walz W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36 (2000) 291-300
41. Yeung S.Y., Millar J.A., and Mathie A. Inhibition of neuronal Kv potassium currents by the antidepressant drug, fluoxetine. Br. J. Pharmacol. 128 (1999) 1609-1615